With increasing legislation legalizing marijuana both in Canada and the United States, companies involved in the development of cannabis for medical and "other" purposes are gaining attention.
But weed stocks, as they are often referred to, have been taking a beating lately, with data showing that many of the stock dumps are sales by executives of major cannabis companies. Is this profit taking, or a reaction to AG Jeff Sessions, who has been an outspoken opponent of legalized marijuana, implying that he might consider a rollback to restore marijuana laws under federal jurisdiction? It's anybody's guess. But rather than rush to unload a company before it goes up in smoke (see what I did there…) it's worth taking a look at additional assets that a cannabis company may hold.
Top Medical Stocks To Own Right Now: Euro FX(P)
Advisors' Opinion:- [By Rick Munarriz]
It didn't take long for Sirius XM Holdings (NASDAQ:SIRI) to start leveraging its Pandora (NYSE:P) acquisition. Less than a week after closing on its purchase of the streaming-music pioneer in a roughly $3 billion deal, Sirius XM sent out an email offer to its satellite-radio subscribers for a free 14-day trial to Pandora's premium platform.
- [By Chris Lange]
Pandora Media Inc. (NYSE: P) shares shot up early on Monday after it was announced that the company would be acquired by Sirius XM Holdings Inc. (NASDAQ: SIRI). The transaction is expected to close in the first quarter of 2019.
- [By Steve Symington]
Pandora Media (NYSE:P) announced strong second-quarter 2018 results on Tuesday after the market closed, detailing accelerated revenue growth, improved ad-hour trends, and new partnerships that could further spur its momentum.
- [By Steve Symington]
Pandora Media (NYSE:P) announced significantly better-than-expected first-quarter 2018 results on Thursday after the market closed, and shares of the music-streaming specialist are up more than 21% in Friday's early trading in response.
Top Medical Stocks To Own Right Now: MEDIFAST INC(MED)
Advisors' Opinion:- [By Logan Wallace]
MediBloc [MED] (CURRENCY:MED) traded 11.7% lower against the U.S. dollar during the 1 day period ending at 20:00 PM ET on February 16th. MediBloc [MED] has a total market capitalization of $19.63 million and $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours. During the last seven days, MediBloc [MED] has traded down 27.6% against the U.S. dollar. One MediBloc [MED] token can currently be bought for $0.0066 or 0.00000100 BTC on major exchanges including Coinrail, Bibox and Gate.io.
- [By Joseph Griffin]
MediBloc [QRC] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. Its genesis date was January 3rd, 2014. MediBloc [QRC]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC] is medibloc.org/en. MediBloc [QRC]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC] is /r/MediBloc and the currency’s Github account can be viewed here. The official message board for MediBloc [QRC] is medium.com/@MediBloc.
- [By Max Byerly]
McCormick & Company, Incorporated (NYSE: MKC) and Medifast (NYSE:MED) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.
Top Medical Stocks To Own Right Now: First Busey Corporation(BUSE)
Advisors' Opinion:- [By Ethan Ryder]
BidaskClub downgraded shares of First Busey (NASDAQ:BUSE) from a buy rating to a hold rating in a research report sent to investors on Saturday morning.
- [By Max Byerly]
Get a free copy of the Zacks research report on First Busey (BUSE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new stake in shares of First Busey Co. (NASDAQ:BUSE) during the 1st quarter, Holdings Channel reports. The firm bought 7,000 shares of the bank’s stock, valued at approximately $208,000.
- [By Max Byerly]
First Busey Co. (NASDAQ:BUSE) – Equities researchers at B. Riley decreased their Q2 2018 earnings estimates for First Busey in a report released on Tuesday, June 19th. B. Riley analyst S. Moss now expects that the bank will post earnings per share of $0.53 for the quarter, down from their previous forecast of $0.57. B. Riley has a “Buy” rating and a $36.00 price objective on the stock. B. Riley also issued estimates for First Busey’s Q3 2018 earnings at $0.55 EPS, Q4 2018 earnings at $0.59 EPS, FY2018 earnings at $2.18 EPS, Q1 2019 earnings at $0.57 EPS, Q3 2019 earnings at $0.59 EPS, Q4 2019 earnings at $0.63 EPS and FY2019 earnings at $2.38 EPS.
- [By Logan Wallace]
Get a free copy of the Zacks research report on First Busey (BUSE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on First Busey (BUSE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment